CELGENE CAR LLC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	40
#2	Australia	16
#3	EPO (European Patent Office)	15
#4	WIPO (World Intellectual Property Organization)	6
#5	Canada	4
#6	China	4
#7	Republic of Korea	4
#8	Mexico	3
#9	EAPO (Eurasian Patent Organization)	2
#10	Singapore	2
#11	Brazil	1
#12	Chile	1
#13	Ecuador	1
#14	Israel	1
#15	Philippines	1
#16	Serbia	1
#17	Taiwan	1
#18	Ukraine	1

#	Technology
#1	Heterocyclic compounds
#2	Therapeutic chemical compounds
#3	Medical preparations
#4	Microorganisms
#5	Enzymes
#6	Organic chemistry methods
#7	Acyclic or carbocyclic compounds
#8	Analysing materials
#9	Special acyclic compounds
#10	Peptides

Publication	Filing date	Title
WO2020236636A1	2020-05-15	Methods of treating a mk2-mediated disorder
WO2018170204A1	2018-03-15	9,10,11,12-tetrahydro-8h-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one compounds and uses thereof
MX2019010643A	2018-03-15	Forms and compositions of a mk2 inhibitor.
EP3596083A1	2018-03-15	Heteroaryl compounds useful as mk2 inhibitors
MX2019010642A	2018-03-15	Mk2 inhibitors, synthesis thereof, and intermediates thereto.
US2021122762A1	2018-03-15	Deuterated analogs of mk2 inhibitors and uses thereof
AU2016253570A1	2016-11-02	Heteroaryl compounds and uses thereof
AU2016210613A1	2016-08-02	Heterocyclic compounds and uses thereof
EA037299B1	2015-09-16	Mk2 inhibitors and uses thereof
EP3179858A1	2015-08-12	Forms and compositions of an erk inhibitor
KR20210022140A	2014-03-14	Heteroaryl compounds and uses thereof
AU2013202496A1	2013-04-04	Heteroaryl compounds and uses thereof
RS57901B1	2013-03-13	Salts of an epidermal growth factor receptor kinase inhibitor
KR20180045065A	2009-06-26	Heteroaryl compounds and uses thereof